Company Search:
Advanced Search
Sponsored Links
Imexpharm Corp Company Snapshot
Imexpharm Corp operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Imexpharm Corp with three other companies in this sector in VIETNAM : Mekophar Chemical Pharma JSC (2020 sales of 1.21 trillion Vietnamese Dong [US$52.42 million] ), Medipharco Pharmaceutical JSC (1.01 trillion Vietnamese Dong [US$43.85 million] ), and DOMESCO Medical Import Export Joint Stock Corp (1.45 trillion Vietnamese Dong [US$62.87 million] ).

Sales Analysis. During the year ended December of 2020, sales at Imexpharm Corp were 1.37 trillion Vietnamese Dong (US$59.30 million). This is a decrease of 2.4% versus 2019, when the company's sales were 1.40 trillion Vietnamese Dong .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Imexpharm Corp
  Stock Performance Chart for Imexpharm Corp
  Stock Data: Recent Stock Performance:
  Current Price (4/16/2021): 71,000
(Figures in Vietnamese Dong )
1 Week -2.2%   13 Weeks -2.7%  
4 Weeks 22.0%   52 Weeks 72.2%  
Imexpharm Corp Key Data:
  Ticker: IMP Country: Vietnam
  Exchanges: HCM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2020 Sales 1,369,421,714,781
(Year Ending Jan 2021).
Employees: 605
  Currency: Vietnamese Dong Market Cap: 4,733,681,470,000
  Fiscal Yr Ends: December Shares Outstanding: 66,671,570
  Share Type: Closely Held Shares: 48,562,909
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.